UA96277U - The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis - Google Patents

The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis

Info

Publication number
UA96277U
UA96277U UAU201409159U UAU201409159U UA96277U UA 96277 U UA96277 U UA 96277U UA U201409159 U UAU201409159 U UA U201409159U UA U201409159 U UAU201409159 U UA U201409159U UA 96277 U UA96277 U UA 96277U
Authority
UA
Ukraine
Prior art keywords
pneumosclerosis
perivascular
development
bronchiectasis
peri
Prior art date
Application number
UAU201409159U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Тетяна Ярославівна Бондаренко
Микола Миколайович Островський
Олександр Іванович Варунків
Алла Богданівна Зубань
Original Assignee
Тетяна Ярославівна Бондаренко
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тетяна Ярославівна Бондаренко filed Critical Тетяна Ярославівна Бондаренко
Priority to UAU201409159U priority Critical patent/UA96277U/en
Publication of UA96277U publication Critical patent/UA96277U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis, consisting of general clinical investigation. Additionally, determine the content of collagen type IV in bronchoalveolar fluid and with his index 165,42 ± 7,66 ng / ml and above peribronhialnoy diagnosed preconditions for the development and perivascular pneumosclerosis.
UAU201409159U 2014-08-14 2014-08-14 The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis UA96277U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201409159U UA96277U (en) 2014-08-14 2014-08-14 The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201409159U UA96277U (en) 2014-08-14 2014-08-14 The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis

Publications (1)

Publication Number Publication Date
UA96277U true UA96277U (en) 2015-01-26

Family

ID=52989225

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201409159U UA96277U (en) 2014-08-14 2014-08-14 The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis

Country Status (1)

Country Link
UA (1) UA96277U (en)

Similar Documents

Publication Publication Date Title
EA201400119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR APPLICATION
BR112017019279A2 (en) disposable oxygen reduction kits and devices and methods of use
SG10201803877YA (en) Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-, pro- or synbiotics) for improving the efficacy of a cancer treatment
SG10201903823QA (en) Methods and compositions relating to microbial treatment and diagnosis of disorders
BR112015029318A2 (en) pathway specific markers for the diagnosis of irritable bowel syndrome
EA201692477A1 (en) COMPOSITIONS AND METHODS OF APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS
EA033286B1 (en) Method of treating or delaying the progression of chronic kidney disease
EP4060048A3 (en) Non-invasive diagnostic method for diagnosing bladder cancer
BR112017006113A2 (en) synergistic combinations of auristatin
TN2013000472A1 (en) Induction of immune tolerance by using methotrexate
WO2014197835A3 (en) Methods and compositions for the treatment of cancer
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
EP3980017A4 (en) Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality
EP3285071A4 (en) Biomarker composition for diagnosing still's disease, diagnostic kit, and diagnostic method
WO2014152754A3 (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
WO2014169011A3 (en) Methods for treating immune diseases
MX364003B (en) Treatment of insulin resistance through inhibitors of transcription factor tsc22d4.
EA201491455A1 (en) EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE
UA96277U (en) The method of diagnosis of development and progression of peri bronchial and perivascular pneumosclerosis in patients with chronic bronchitis, complicated by secondary bronchiectasis
WO2015092444A3 (en) Biomarkers
WO2014066860A3 (en) Methods of prognosticating and treating cancer
EA201690217A1 (en) METHOD AND DIAGNOSTIC KIT FOR CONTROL OF MULTIPLE SCLEROSIS (PC)
EP4328245A3 (en) Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations
UA97881U (en) METHOD OF DIAGNOSIS OF THE THREAT OF DEVELOPMENT AND PROGRESSION OF SECONDARY BRONCHOEKTAS IN PATIENTS WITH CHRONIC Bronchitis
PL408305A1 (en) Application of C16 (C16-Cer) ceramide as the biomarker in prediction of premature birth